L. Kong
发表
R. Sang,
Chun-jie Liu,
Yuanyuan Liu,
2020,
Frontiers in Bioengineering and Biotechnology.
L. Kong,
Linlin Zhang,
Nana Yang,
2022,
Frontiers in Pharmacology.
M. Ueno,
N. Takakura,
K. Yoshioka,
2006,
Biochemical and biophysical research communications.
Xianzhi Meng,
Shangha Pan,
Lingling Zheng,
2019,
Cell Death & Disease.
L. Kong,
X. Chen,
Yunyan Wu,
2020,
Aging.
H. Kidoya,
N. Takakura,
Daishi Yamakawa,
2021,
Nature Communications.
Qigesan reduces the motility of esophageal cancer cells via inhibiting Gas6/Axl and NF-κB expression
L. Kong,
Jing Li,
Xin Lu,
2019,
Bioscience reports.
Lingyu Kong,
M. Ueno,
N. Takakura,
2005,
Molecular and Cellular Biology.
Yanni Zhang,
Jian Lv,
Yitao Jia,
2020,
Frontiers in Microbiology.
Benhong Liu,
L. Kong,
Linlin Zhang,
2022,
Frontiers in Pharmacology.
Xi Wang,
L. Kong,
Weiran Liu,
2019,
Oncology reports.
Xin Lu,
Xi Wang,
Yaqi Wang,
2021,
Frontiers in Oncology.
EphB4 overexpression in B16 melanoma cells affects arterial-venous patterning in tumor angiogenesis.
M. Ueno,
H. Kidoya,
N. Takakura,
2007,
Cancer research.
Junjie Bao,
Hongwei Yu,
L. Kong,
2021,
Bioscience reports.
Xianzhi Meng,
Shangha Pan,
Lingling Zheng,
2019,
Cell Death & Disease.
Xiangjun Xu,
M. Fan,
L. Kong,
2020
.